Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lynx1 Capital Management LP. Insider active across 3 companies, notably TScan Therapeutics, Inc.. Cumulatively, 10 reports have been logged. Split: 9 buys · 1 sell. Total volume traded: €3.8m. Activity tracked since 31 May 2023. The latest transaction was filed on 17 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.